Howley Michael G 4

4 · ABIOMED INC · Filed Sep 26, 2018

Form 4

Period: 2018-09-25

Vice President

Transactions

Sale
Common Stock, $.01 par value
2018-09-25$425.00/sh−5,000$2,125,000→ 55,492 total
Sale
Common Stock, $.01 par value
2018-09-25$440.00/sh−5,000$2,200,000→ 50,492 total
Exercise/Conversion
Stock Option (Right to Buy)
2018-09-25−10,000→ 15,000 total
Exercise: $23.15From: 2014-05-14Exp: 2023-05-14→ Common Stock (0 underlying)
Exercise/Conversion
Common Stock, $.01 par value
2018-09-25$23.15/sh+10,000$231,500→ 60,492 total

Holdings

Stock Option (Right to Buy)
Exercise: $381.97From: 2019-05-16Exp: 2028-05-16→ Common Stock (0 underlying)
4,000
Common Stock, $.01 par value
(indirect: By Trust)
2,500
Stock Option (Right to Buy)
Exercise: $66.25From: 2016-05-13Exp: 2025-05-13→ Common Stock (0 underlying)
5,000
Stock Option (Right to Buy)
Exercise: $21.55From: 2015-05-14Exp: 2024-05-14→ Common Stock (0 underlying)
7,500
Stock Option (Right to Buy)
Exercise: $99.62From: 2017-05-24Exp: 2026-05-24→ Common Stock (0 underlying)
8,000
Stock Option (Right to Buy)
Exercise: $134.51From: 2018-05-15Exp: 2027-05-15→ Common Stock (0 underlying)
6,500

Footnotes (6)

[F1]Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
[F2]These options become exerciseable in annual 25% increments, commencing on the date shown forth in Table II, Column 6.
[F3]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
[F4]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
[F5]Exercise of stock options pursuant to reporting owner's 10b5-1 plan.
[F6]Sale of common stock pursuant to reporting owner's 10b5-1 plan.

Documents

2 files